Company Profile

Nanjing Forssmann Medical Technology Co., Ltd., was founded in September 2014 and located in Nanjing Biomedical Valley It provides advanced medical imaging, diagnostic and healthcare information technology solutions. “Better for more” is our tenet and we are committed to research and develop the most innovative interventional cardiovascular diagnostic and therapeutic devices so that we are able to provide high-quality products and services to more and more patients.

0
Company founded
> 0
Intellectual Property
> 0
GMP plant
> 0
R&D Staff
  • The Forssmann Medical Preparatory Committee met in Qingliang Mountain Park (the historic Nanjing crematorium) and decided to set up five innovative medical projects.
2012
  • We were born in the Jinling Manufacturing Bureau by the Qinhuai River - 1865 Industrial Park
2014
  • In April 2015, the intravascular imaging catheter technology has achieved significant progress.
  • In April 2015, the first Forssmann Biomedical Engineering Forum was held at Nanjing University.
  • In November 2015, the first prototype of Forssmann intravascular OCT was successfully developed.
2015
  • In February 2016, the first production line started operation and R&D base was established in Jiangbei New District.
  • In April 2016, animal experiments of the intravascular OCT system and imaging catheter had been accomplished. The national medical device product registration inspection has been officially started whereafter
  • In May 2016, the company awarded the honor of "Jiangsu Province Science and Technology-based Small and Medium-sized Enterprises". No. 16320111KJQY000034
  • In June 2016, we won the project of "Digital Diagnosis and Treatment Special Project" of National Key Research and Development Program. Project No.: 2016YFC0100500
  • In October 2016, the intravascular imaging catheter obtained the qualification of special review for Medical Devices from National Medical Products Administration (NMPA). Approval No. 201600115
2016
  • The 10th Forssmann Biomedical Engineering Forum was held at Nanjing University.
  • In May 2017, the company has been accredited the Workstation of Jiangsu Provincial Graduate Students ".
  • In June 2017, we won the first place in the biomedical group of Jiangsu Provincial Scientific and Technological Achievement Transformation Project, and obtained the project. No. BA2017001
  • In September 2017, we won the sixth place in the biomedical final of the Sixth National Innovation and Entrepreneurship Competition of the Ministry of Science and Technology.
  • In November 2017, second product was qualified for the special approval channel for medical devices from National Medical Products Administration (NMPA). Approval No. 201700177
2017
  • In February 2018, we obtained the title of Jiangbei New District Biomedical 2018 Leading Enterprises.
  • In April 2018, CHC Summit honored Forssmann with 2017 Best Newcomer Award in China's Healthcare Industry
  • In August 2018, we completed the clinical enrollment of intravascular OCT system and imaging catheter, and formally submitted to the National Medical Products Administration (NMPA) for registration.
2018
  • In January 2019, we received the Second Prize for Scientific and Technological Progress 2018 from the Ministry of Education.
  • In March 2019, intravascular OCT system and intravascular imaging catheter were approved for registration by the National Medical Products Administration (NMPA) in March and August, respectively, thus making our products the first import-substitute products on the market in China.
  • In May 2019, we received ISO13485 13485 certification, No. MD 703857
  • In December 2019, we obtained the "Digital Diagnosis and Treatment Special Project" of National Key Research and Development Program. Project No. 2019YFC0120700
2019
  • In February 2020, we obtained National High-tech Enterprise Qualification, No. GR201932001084
  • In June 2020, we completed B round of financing of 110 million RMB.
  • In July 2020, our intravascular OCT system obtained CE certificate. Certificate No.: CE 703854
  • In September 2020, the second generation of intravascular OCT system was approved by the National Medical Products Administration (NMPA) for marketing.
  • In December 2020, the number of hospitals with product admissions and trials has been exceeded 100.
2020
  • In February 2018, we obtained the title of Jiangbei New District Biomedical 2018 Leading Enterprises.
  • In February 2021, we signed a strategic partnership agreement with Bluesail .
  • In March 2021, we completed the B+ round of financing of 200 million RMB.
  • In June 2021, the company was accredited Unicorn Cultivation Enterprise.
  • In November 2021, intravascular OCT was admitted to more than 500 hospitals.
2021年
。。。。。。
2022年

沃福曼人首先要对所有使用我们的产品和服务的人负责。我必须明确为她们提供先进、安全,便捷的医疗产品是我们最高责任。我们必须坚持科研投入并承担失败加以改正。我们必须不断追求产品和服务的创新,我们必须坚持以最高质量标准来满足医患要求。在神圣的生命面前做到从不妥协。

沃福曼人要对一起工作的伙伴负责,我们必须为他们提供安全、可靠和整洁的工作环境,我们必须维护他们的权益和尊严并赞美他们的优点,我们必须提升和培养他们的工作技能,所提供的薪酬必须公平合理。

沃福曼人要对我们所生活的国家和世界负责,我们必须用我们的工作促进行业的发展,推动社会的进步。我们必须遵纪守法,履行我们的社会责任和义务。我们必须倡导热爱祖国、热爱事业、热爱家庭,保护资源和环境。

“为了更多的人”是我们创立的愿景,在神圣的生命事业进步路上,我们心手相连,携手同行,致力成为中国先进医疗产业的代表。我们誓为医学进步恪尽职守,实现我们对生命的庄严承诺!

Our Team

Fossmann has a professional and persistent core team with foster continuous learning, which is also dedicated, enthusiastic and energetic. Our team members have been cultivated professionally more than 15 years averagely. And we understands the importance of health to every person and family, thus we actively engaged in the innovative medical care, for committing to better delivery of advanced medical technology, pursuiting to excellence, and striving to provide excellent products and services for doctors and patients.

Social Responsibility

Adhering to the humanistic idea of “better for more”, we are dedicated to social welfare in our spare time. We are going into public welfare organizations, villages and hospitals to bring help and care to the needy groups as much as we can. And we approach primary and secondary schools to let more children know about health and science. We have set up the Forssmann Overseas Exchange Funds in universities , such as School of engineering and applied sciences of Nanjing University, aiming to encourage young students to enter into advanced laboratories, companies and universities abroad and to have academic exchanges with international advanced counterparts, ultimately to promote the development of advanced science and technology in the field of human health. We set up the Forssmann Biomedical Engineering Forum to bring industry leaders into universities to inform students and faculty about the opportunities and challenges of today’s medical field and to discuss the gains and losses in clinical technology. We have set up the Forssmann Academic Achievement Award at academic conferences, including the International Cerebrovascular Disease Summit, to reward talented individuals in the fields of medicine and engineering for their contributions to the advancement of development. Fossmann people have never compromised on the path of advancing the sacred progress of life and health, Whether it is a rational and objective analysis or an emotional and spiritual quest, all efforts and actions we make hopefully can be transformed into a driving force for the advancement of medical progress.
In the past, today and future, Fossmann people have been working hard ……

Honors

  • Unicorn cultivation enterprise
  • Postgraduate workstation in Jiangsu Province.
  • The Best Newcomer Award in China’s Healthcare Industry of 2017 CHC Summit
  • The 6th place in the Biomedical Finals of the 2017 China Innovation and Entrepreneurship Competition by the Ministry of Science and Technology.
  • Second Prize of Science and Technology Progress in 2018 by Ministry of Education.
  • Hosting and undertaking 3 projects of National Key Research and Development Program.
  • Presiding unit of Jiangsu Province Scientific and Technological Achievement Transformation Program in 2017

奖项荣誉